Literature DB >> 9570491

Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function.

P H Lysaker1, M D Bell, G Bryson, E Kaplan.   

Abstract

It remains unclear how impaired insight and neurocognitive impairment are related to one another in schizophrenia. In order to examine this relationship, subjects with schizophrenia or schizoaffective disorder were classified as having 'impaired' (n=38) or 'unimpaired' (n=43) insight based on their insight rating on the Positive and Negative Syndrome Scale (PANSS). Their performance on neuropsychological tests of global function, executive function, memory and vigilance was then compared. Multivariate analyses followed by Scheffe tests indicated that subjects with impaired insight performed less well on the Wisconsin Card Sorting Test, demonstrating poorer abstract flexibility and heightened perseveration. No differences were found between the groups with regard to global cognitive function, memory or vigilance. This suggests that insight is closely linked to deficits in executive function, and that it may be associated with the compromise of frontal lobe function.

Entities:  

Mesh:

Year:  1998        PMID: 9570491     DOI: 10.1111/j.1600-0447.1998.tb10003.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  15 in total

1.  Characterizing a psychiatric symptom dimension related to deficits in goal-directed control.

Authors:  Claire M Gillan; Michal Kosinski; Robert Whelan; Elizabeth A Phelps; Nathaniel D Daw
Journal:  Elife       Date:  2016-03-01       Impact factor: 8.140

2.  The clinical applicability of the Self-Appraisal of Illness Questionnaire (SAIQ) to chronic schizophrenic patients in Taiwan.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2010-09

Review 3.  Insight in bipolar disorder.

Authors:  Klára Látalová
Journal:  Psychiatr Q       Date:  2012-09

4.  White matter integrity and lack of insight in schizophrenia and schizoaffective disorder.

Authors:  Daniel Antonius; Vasthie Prudent; Yasmina Rebani; Debra D'Angelo; Babak A Ardekani; Dolores Malaspina; Matthew J Hoptman
Journal:  Schizophr Res       Date:  2011-03-22       Impact factor: 4.939

5.  Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study.

Authors:  Mara Parellada; Leticia Boada; David Fraguas; Santiago Reig; Josefina Castro-Fornieles; Dolores Moreno; Ana Gonzalez-Pinto; Soraya Otero; Marta Rapado-Castro; Montserrat Graell; Inmaculada Baeza; Celso Arango
Journal:  Schizophr Bull       Date:  2010-09-30       Impact factor: 9.306

6.  Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: the West London first episode study.

Authors:  Stanley H Mutsatsa; Eileen M Joyce; Sam B Hutton; Thomas R E Barnes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-04       Impact factor: 5.270

7.  Empirically defined patterns of executive function deficits in schizophrenia and their relation to everyday functioning: a person-centered approach.

Authors:  Mary Iampietro; Tania Giovannetti; Deborah A G Drabick; Rachel K Kessler
Journal:  Clin Neuropsychol       Date:  2012-10-04       Impact factor: 3.535

8.  Insight, cognitive dysfunction and symptomatology in schizophrenia.

Authors:  Luciana C Monteiro; Vanessa A Silva; Mario R Louzã
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

9.  Neurocognitive and psychopathological correlates of self-monitoring ability in schizophrenia.

Authors:  Jimmy Jensen; Lise-Lotte Nilsson; Sten Levander
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-10       Impact factor: 5.270

10.  Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users.

Authors:  Robert Hester; Liam Nestor; Hugh Garavan
Journal:  Neuropsychopharmacology       Date:  2009-06-24       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.